USPTO serial 87277841
T ACCESS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 14, 2017
- Examiner
- SEVERSON, KAREN
- Law office
- —
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with T ACCESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maren C. Perry
Maren C. Perry King & Spalding LLP1185 Avenue of the AmericasNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes ] | SECTION 8 - CANCELLED | — |
| 041 | [ Educational services, namely, providing classes, courses, and seminars in the field of medicine and disease prevention; providing medical training; arranging and conducting seminars, educational conferences, symposiums, workshops and courses in the field of medicine and disease prevention; educational services, namely, providing classes, seminars, workshops, and training in the fields of scientific research and development in the fields of pharmaceuticals, science, pharmaceutical clinical studies, tests and trials, medical diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; providing the aforementioned services electronically, via cable or Internet or other electronic media; arranging and conducting in-person educational forums in the fields of medicine and pharmaceuticals; on-line training programs in the fields of medicine and pharmaceuticals; providing temporary use of online non-downloadable publications in the nature of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, and teaching and educational curriculum in the fields of medical and pharmaceutical research and development ] | SECTION 8 - CANCELLED | — |
| 042 | [ Scientific and technological services, namely, research and design in the field of medicine; industrial analysis and research services in the field of pharmaceuticals; providing temporary use of online non-downloadable software for accessing an online searchable database in the fields of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research in the fields of medical disorders, diseases, disease prevention, central nervous system, neurological disorders, and central nervous system disorders, diseases, and related pharmaceuticals; medical research, namely, conducting medical trials and tests for others in the field of pharmaceuticals; conducting clinical research, trials, and testing for others in the field of pharmaceuticals; medical diagnostic research and tests and clinical trials for others; providing medical and pharmaceutical information in the field of research and development, science, clinical trials and tests ] | SECTION 8 - CANCELLED | — |
| 044 | Medical services; healthcare services; therapeutic clinical services in the field of brain and central nervous systems diseases and disorders; providing medical and healthcare information; providing information in the field of the therapeutic properties of pharmaceuticals; psychiatry and clinical psychology services in the fields of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical information in the field of diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; providing online medical data and analyses designed to provide patients and clients with customized medical information regarding medical dosing, medical diagnoses, therapeutic counseling services, and non-surgical medical management of diseases and medical disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named T ACCESS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 22, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 22, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Mar 22, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 23, 2024 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jan 23, 2024 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jan 23, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 13, 2023 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Nov 14, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 14, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 19, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 19, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 19, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 19, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 5, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 1, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 29, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 6, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 27, 2016 | NWAP | NEW APPLICATION ENTERED | — |